Kingsview Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.23M | Buy |
25,693
+6,226
| +32% | +$596K | 0.03% | 488 |
|
|
2025
Q4 | $1.87M | Buy |
19,467
+2,506
| +15% | +$243K | 0.03% | 486 |
|
|
2025
Q3 | $1.62M | Buy |
16,961
+999
| +6% | +$91.8K | 0.02% | 497 |
|
|
2025
Q2 | $1.39M | Sell |
15,962
-1,270
| -7% | -$108K | 0.02% | 500 |
|
|
2025
Q1 | $1.55M | Sell |
17,232
-1,494
| -8% | -$134K | 0.03% | 442 |
|
|
2024
Q4 | $1.5M | Sell |
18,726
-2,223
| -11% | -$192K | 0.03% | 459 |
|
|
2024
Q3 | $1.89M | Buy |
20,949
+2,197
| +12% | +$185K | 0.04% | 387 |
|
|
2024
Q2 | $1.48M | Buy |
18,752
+751
| +4% | +$61.6K | 0.03% | 416 |
|
|
2024
Q1 | $1.57M | Sell |
18,001
-49,686
| -73% | -$4.24M | 0.04% | 394 |
|
|
2023
Q4 | $5.58M | Buy |
67,687
+11,552
| +21% | +$880K | 0.17% | 142 |
|
|
2023
Q3 | $4.4M | Buy |
56,135
+3,173
| +6% | +$266K | 0.16% | 151 |
|
|
2023
Q2 | $4.67M | Sell |
52,962
-923
| -2% | -$79.5K | 0.18% | 122 |
|
|
2023
Q1 | $4.34M | Sell |
53,885
-7,266
| -12% | -$592K | 0.18% | 121 |
|
|
2022
Q4 | $4.75M | Buy |
61,151
+4,854
| +9% | +$393K | 0.21% | 121 |
|
|
2022
Q3 | $4.55M | Buy |
56,297
+975
| +2% | +$87.6K | 0.22% | 111 |
|
|
2022
Q2 | $4.96M | Sell |
55,322
-17,127
| -24% | -$1.74M | 0.24% | 103 |
|
|
2022
Q1 | $8.04M | Buy |
72,449
+3,044
| +4% | +$322K | 0.35% | 63 |
|
|
2021
Q4 | $7.18M | Buy |
69,405
+1,796
| +3% | +$208K | 0.3% | 72 |
|
|
2021
Q3 | $8.47M | Buy |
67,609
+3,034
| +5% | +$393K | 0.4% | 47 |
|
|
2021
Q2 | $8.14M | Buy |
64,575
+4,510
| +8% | +$566K | 0.4% | 46 |
|
|
2021
Q1 | $7.1M | Buy |
60,065
+11,550
| +24% | +$1.35M | 0.4% | 53 |
|
|
2020
Q4 | $5.68M | Buy |
48,515
+600
| +1% | +$66.1K | 0.41% | 51 |
|
|
2020
Q3 | $4.98M | Sell |
47,915
-2,718
| -5% | -$273K | 0.45% | 56 |
|
|
2020
Q2 | $4.64M | Sell |
50,633
-3,771
| -7% | -$362K | 0.46% | 49 |
|
|
2020
Q1 | $4.91M | Buy |
54,404
+9,993
| +23% | +$1.06M | 0.66% | 31 |
|
|
2019
Q4 | $5.04M | Buy |
44,411
+1,935
| +5% | +$212K | 0.63% | 33 |
|
|
2019
Q3 | $4.61M | Buy |
42,476
+624
| +1% | +$65.1K | 0.72% | 31 |
|
|
2019
Q2 | $4.08M | Buy |
41,852
+380
| +0.9% | +$34.7K | 0.68% | 35 |
|
|
2019
Q1 | $3.78M | Buy |
41,472
+8,221
| +25% | +$736K | 0.57% | 40 |
|
|
2018
Q4 | $3.02M | Sell |
33,251
-1,341
| -4% | -$125K | 0.66% | 38 |
|
|
2018
Q3 | $3.4M | Buy |
34,592
+2,758
| +9% | +$255K | 0.69% | 35 |
|
|
2018
Q2 | $2.73M | Buy |
31,834
+446
| +1% | +$37.3K | 0.65% | 44 |
|
|
2018
Q1 | $2.52M | Buy |
31,388
+25,437
| +427% | +$2.1M | 0.63% | 44 |
|
|
2017
Q4 | $481K | Buy |
+5,951
| New | +$477K | 0.17% | 177 |
|
Other funds holding MDT
VCM
VPM
Kingsview Wealth Management's MDT Position: Q1 2026 in Review
Kingsview Wealth Management increased its Medtronic (MDT) stake by 32% in Q1 2026, buying an estimated $596K and bringing the position to 25,693 shares worth $2.23M. The position accounts for 0.03% of the portfolio, ranked #488.
Kingsview Wealth Management first reported a position in MDT in Q4 2017 and has held it in 34 quarters since. The position peaked at $8.47M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Kingsview Wealth Management held 25,693 shares of Medtronic worth $2.23M as of Q1 2026.
- Kingsview Wealth Management bought 6,226 Medtronic shares in Q1 2026, an estimated $596K.
- Medtronic made up 0.03% of Kingsview Wealth Management's portfolio in Q1 2026, its #488 holding.
- Kingsview Wealth Management first reported a position in Medtronic in Q4 2017 and has held it in 34 quarters since.
- Kingsview Wealth Management's Medtronic position peaked at $8.47M in Q3 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.